Turning Point Therapeutics, Inc. TPTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

1/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Turning Point Therapeutics, Inc. (TPTX), dont 18 achats et 26 ventes. Le total des achats d'initiés s'élève à $5.13M et le total des ventes d'initiés à $22.97M.

Les initiés notables ayant une activité récente comprennent Machado Patrick, Gallagher Carol Giltner, Alles Mark J. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — TPTX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2022-08-17	Machado Patrick	Director	Restitution d'Actions	30,000	-	-	-
2022-08-17	Gallagher Carol Giltner	Director	Restitution d'Actions	30,000	$39.99	$1.2M	-
2022-08-17	Alles Mark J	Director	Restitution d'Actions	209	-	-	-
2022-08-17	Countouriotis Athena	President & CEO	Restitution d'Actions	224,640	$37.68	$8.46M	-
2022-08-17	George Simeon	Director	Restitution d'Actions	8,500	-	-	-
2022-08-17	Nicholson Garry A	Director	Restitution d'Actions	8,500	$65.64	$557.94K	-
2022-08-17	Hirmand Mohammad	EVP and Chief Medical Officer	Restitution d'Actions	41,284	$76.00	$3.14M	-
2022-08-17	Tombesi Paolo	EVP & Chief Financial Officer	Restitution d'Actions	29,778	$76.00	$2.26M	-
2022-08-17	Bodem Barbara W.	Director	Restitution d'Actions	14,995	$94.59	$1.42M	-
2022-08-17	Sun Brian	SVP & General Counsel	Restitution d'Actions	45,000	$76.00	$3.42M	-
2022-08-17	Sabus Steve M	SVP & Chief Commercial Officer	Restitution d'Actions	165,000	-	-	-
2022-07-27	Tombesi Paolo	EVP & Chief Financial Officer	Vente Informative	1,183	$74.94	$88.65K	28,700
2022-05-31	Sabus Steve M	Officer	Inconnu	-	-	-	-
2022-05-31	Sabus Steve M	SVP & Chief Commercial Officer	Attribution de RSU	165,000	-	-	165,000
2022-04-11	Sun Brian	Officer	Inconnu	-	-	-	-
2022-04-11	Sun Brian	SVP & General Counsel	Attribution de RSU	195,000	-	-	195,000
2022-02-09	North Annette	EVP & General Counsel	Vente Informative	669	$36.30	$24.28K	11,696
2022-02-09	Reich Siegfried	EVP & Chief Scientific Officer	Vente Informative	397	$36.30	$14.41K	3,448
2022-02-09	Countouriotis Athena	President & CEO	Vente Informative	2,971	$36.30	$107.85K	47,930
2022-02-09	Hirmand Mohammad	EVP & Chief Medical Officer	Vente Informative	669	$36.30	$24.28K	6,838
2022-02-09	Tombesi Paolo	EVP & Chief Financial Officer	Attribution de RSU	16,283	-	-	29,883
2022-02-09	Partridge Andrew John	EVP & Chief Commercial Officer	Vente Informative	221	$36.30	$8.02K	22,078
2021-08-30	North Annette	EVP, General Counsel & Secty.	Vente Informative	10,000	$80.00	$800K	12,365
2021-07-26	Tombesi Paolo	Officer	Inconnu	-	-	-	-
2021-07-26	Tombesi Paolo	EVP & Chief Financial Officer	Attribution de RSU	13,600	-	-	13,600
2021-07-14	Partridge Andrew John	EVP & Chief Commercial Officer	Vente Informative	1,869	$74.90	$139.99K	21,767
2021-06-21	Alles Mark J	Director	Achat Informatif	2,000	$81.34	$162.68K	2,000
2021-06-15	North Annette	EVP, General Counsel & Secty.	Vente Informative	6,634	$77.82	$516.26K	12,365
2021-06-02	Machado Patrick	Director	Attribution de RSU	8,500	$65.64	$557.94K	8,500
2021-06-02	Gallagher Carol Giltner	Director	Attribution de RSU	8,500	$65.64	$557.94K	8,500
2021-06-02	Alles Mark J	Director	Attribution de RSU	209	$65.64	$13.72K	209
2021-06-02	George Simeon	Director	Attribution de RSU	8,500	$65.64	$557.94K	8,500
2021-06-02	Nicholson Garry A	Director	Attribution de RSU	8,500	$65.64	$557.94K	8,500
2021-05-24	Alles Mark J	Director	Inconnu	-	-	-	-
2021-05-24	Alles Mark J	Director	Attribution de RSU	17,000	$70.60	$1.2M	17,000
2021-05-14	Van Hoose Kyri K.	Officer	Inconnu	-	-	-	-
2021-05-06	North Annette	EVP, General Counsel & Secty.	Exercice d'Options	5,882	$17.00	$99.99K	12,365
2021-03-31	Bodem Barbara W.	Director	Inconnu	-	-	-	-
2021-03-31	Bodem Barbara W.	Director	Attribution de RSU	14,995	$94.59	$1.42M	14,995
2021-03-23	Baker Brian Lee	SVP of Finance and Admin.	Exercice d'Options (Vente)	1,298	$3.20	$4.15K	-
2021-03-22	Baker Brian Lee	SVP of Finance and Admin.	Attribution de RSU	1,625	-	-	4,116
2021-03-08	North Annette	EVP, General Counsel & Secty.	Vente Informative	700	$111.69	$78.18K	6,483
2021-03-04	Reich Siegfried	EVP & Chief Scientific Officer	Vente Informative	600	$111.46	$66.88K	3,845
2021-02-11	Countouriotis Athena	President & CEO	Vente Informative	3,052	$138.55	$422.85K	50,195
2021-02-10	Countouriotis Athena	President & CEO	Vente Informative	433	$138.19	$59.84K	50,195
2021-02-09	Countouriotis Athena	President & CEO	Vente Informative	1,104	$140.24	$154.82K	50,195
2021-02-08	North Annette	EVP, General Counsel & Secty.	Attribution de RSU	6,483	-	-	6,483
2021-02-08	Reich Siegfried	EVP & Chief Scientific Officer	Attribution de RSU	3,845	-	-	3,845
2021-02-08	Countouriotis Athena	President & CEO	Attribution de RSU	22,617	-	-	50,195
2021-02-08	Hirmand Mohammad	EVP and Chief Medical Officer	Attribution de RSU	6,483	-	-	6,767

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration